HEALTH● LOWAug 17 · Aug 17, 2026, 2:34 PM
Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
Yahoo Finance
Eli Lilly and Company's (LLY) weight-loss pill has been approved in Europe, though Novo Nordisk A/S (NVO) retains a market advantage. This marks a new development in the competitive weight-loss drug market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoNAFDAC records 213 raids, 474 new cases in eight monthsPremium TimesHEALTHBREAKING1h agoKenya reports second Ebola case, family member of first patientFrance 24 [en]HEALTH1h agoVanda puts anxiety drug program on hold after Phase III setbackSeeking Alpha TechHEALTH2h agoSuspected Fake Surgeon Arrested In Rivers State, Eight Facilities SealedChannels TV